Comparative Pharmacology
Head-to-head clinical analysis: ADVIL DUAL ACTION WITH ACETAMINOPHEN versus ANAPROX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ADVIL DUAL ACTION WITH ACETAMINOPHEN versus ANAPROX.
ADVIL DUAL ACTION WITH ACETAMINOPHEN vs ANAPROX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis. Acetaminophen is an analgesic and antipyretic whose mechanism is not fully understood but involves inhibition of cyclooxygenase in the central nervous system and modulation of the endocannabinoid system.
Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis, which mediates inflammation, pain, and fever.
One caplet (ibuprofen 250 mg and acetaminophen 500 mg) orally every 8 hours while symptoms persist; maximum: 3 caplets per day.
250-500 mg orally twice daily; maximum 1.5 g/day; for extended-release: 375-750 mg orally twice daily
None Documented
None Documented
Ibuprofen: 2-4 hours; Acetaminophen: 2-3 hours. Clinical context: Short half-lives require dosing every 6-8 hours. Extended half-life in overdose (acetaminophen >4 hours indicates toxicity).
Terminal elimination half-life 12-17 hours; prolonged in elderly (up to 20 hours) and in renal impairment.
Ibuprofen: renal (90% as metabolites and conjugates, <10% unchanged); Acetaminophen: renal (85% as sulfate and glucuronide conjugates, 4% unchanged, 9% as cysteine and mercapturic acid conjugates; minor biliary).
Renal excretion of metabolites (95%) and unchanged drug (<5%); biliary/fecal elimination minor (<5%).
Category C
Category C
NSAID/Analgesic Combination
NSAID